Infliximab treatment of severe ankylosing spondylitis: one-year followup

Arthritis Rheum. 2001 Dec;44(12):2936-7. doi: 10.1002/1529-0131(200112)44:12<2936::aid-art483>3.0.co;2-m.

Authors

J Brandt, H Haibel, J Sieper, J Reddig, J Braun

PMID: 11762956
DOI: 10.1002/1529-0131(200112)44:12<2936::aid-art483>3.0.co;2-m

No abstract available

Publication types

Comment
Letter

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Antirheumatic Agents / therapeutic use*
Follow-Up Studies
Humans
Infliximab
Spondylitis, Ankylosing / therapy*

Substances

Antibodies, Monoclonal
Antirheumatic Agents
Infliximab